Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Brugia malayi | RNA recognition motif domain containing protein | 0.0062 | 0.2197 | 0.2197 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0086 | 0.3859 | 1 |
Brugia malayi | RNA binding protein | 0.0062 | 0.2197 | 0.2197 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0049 | 0.1278 | 0.1278 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0086 | 0.3859 | 1 |
Echinococcus granulosus | thyroid hormone receptor alpha | 0.0159 | 0.8882 | 1 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0049 | 0.1278 | 0.1278 |
Onchocerca volvulus | Steroid hormone receptor family member cnr14 homolog | 0.0031 | 0 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0086 | 0.3859 | 1 |
Giardia lamblia | NADPH oxidoreductase, putative | 0.0086 | 0.3859 | 0.5 |
Brugia malayi | TAR-binding protein | 0.0062 | 0.2197 | 0.2197 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0086 | 0.3859 | 1 |
Trichomonas vaginalis | NAD(P)H dehydrogenase, putative | 0.0086 | 0.3859 | 1 |
Loa Loa (eye worm) | RNA binding protein | 0.0062 | 0.2197 | 0.2197 |
Trichomonas vaginalis | NAD(P)H dehydrogenase, putative | 0.0086 | 0.3859 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0086 | 0.3859 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0062 | 0.2197 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0086 | 0.3859 | 1 |
Onchocerca volvulus | Bile acid receptor homolog | 0.0031 | 0 | 0.5 |
Onchocerca volvulus | 0.0031 | 0 | 0.5 | |
Trichomonas vaginalis | conserved hypothetical protein | 0.0086 | 0.3859 | 1 |
Onchocerca volvulus | Protein ultraspiracle homolog | 0.0031 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0049 | 0.1278 | 0.1278 |
Echinococcus granulosus | tar DNA binding protein | 0.0062 | 0.2197 | 0.2473 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0086 | 0.3859 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0034 | 0.0204 | 0.0204 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0086 | 0.3859 | 1 |
Loa Loa (eye worm) | steroid hormone receptor | 0.0175 | 1 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0034 | 0.0204 | 0.0927 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0049 | 0.1278 | 0.1278 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0034 | 0.0204 | 0.0204 |
Trichomonas vaginalis | NAD(P)H dehydrogenase, putative | 0.0086 | 0.3859 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0062 | 0.2197 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0062 | 0.2197 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0086 | 0.3859 | 1 |
Loa Loa (eye worm) | TAR-binding protein | 0.0062 | 0.2197 | 0.2197 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0062 | 0.2197 | 0.2197 |
Echinococcus multilocularis | tar DNA binding protein | 0.0062 | 0.2197 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0086 | 0.3859 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0062 | 0.2197 | 1 |
Giardia lamblia | NADPH oxidoreductase, putative | 0.0086 | 0.3859 | 0.5 |
Schistosoma mansoni | tar DNA-binding protein | 0.0062 | 0.2197 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0086 | 0.3859 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0086 | 0.3859 | 1 |
Giardia lamblia | NADPH oxidoreductase, putative | 0.0086 | 0.3859 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Inhibition (functional) | < 30 % | Antituberculosis activity against Mycobacterium tuberculosis H37Rv assessed as complete growth inhibition at 20 uM after 5 days | ChEMBL. | 25456390 |
MIC99 (functional) | Antituberculosis activity against Mycobacterium tuberculosis H37Rv assessed as complete growth inhibition after 5 days | ChEMBL. | 25456390 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.